Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor. (2013)
Attributed to:
UNITED KINGDOM CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA RANDOMISED TRIAL 2003 (MRC UKALL 2003)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/leu.2013.136
PubMed Identifier: 23636228
Publication URI: http://europepmc.org/abstract/MED/23636228
Type: Journal Article/Review
Volume: 27
Parent Publication: Leukemia
Issue: 11
ISSN: 0887-6924